Submit Feedback
Recent searches
    Trending searches
    +

    Agilent Technologies Competitors & Alternatives

    Agilent Technologies competitors and alternatives include Thermo Fisher Scientific, Danaher Corporation, etc.…

    Jump
    Company
    Ticker
    A
    TMO
    DHR
    Headquarter
    Santa Clara ,CA
    US
    Waltham ,MA
    US
    Washington ,DC
    US
    CEO
    Mr. Rodney Gonsalves
    Mr. Marc N. Casper
    Mr. Rainer M. Blair
    Industry
    Medical - Diagnostics & Research
    Medical - Diagnostics & Research
    Medical - Diagnostics & Research
    Stock Price
    Stock Price
    Market Cap
    $38.75B
    $203.50B
    $169.62B
    Employees
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Employees
    • 18.10K
    • 18.10K
    • 17.90K
    • 130.00K
    • 122.00K
    • 81.00K
    • 63.00K
    Y/Y
    6.47%
    0%
    1.1%
    0%
    6.15%
    1.25%
    22.22%

    Income Statement

    Revenue
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Revenue
    • $6.85B
    • $6.83B
    • $6.51B
    • $44.92B
    • $42.86B
    • $31.47B
    • $23.89B
    Y/Y
    8.37%
    0.22%
    4.73%
    14.55%
    4.58%
    6.85%
    24.09%
    Revenue by Products / Services
    Revenue by Geography
    Research and Development
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Research and Development
    • $467.00M
    • $481.00M
    • $479.00M
    • $1.47B
    • $1.34B
    • $1.75B
    • $1.50B
    Y/Y
    5.9%
    3%
    0.42%
    4.62%
    9.11%
    0.17%
    13.87%
    Operating Income
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Operating Income
    • $1.62B
    • $1.35B
    • $1.49B
    • $8.39B
    • $6.86B
    • $8.69B
    • $5.20B
    Y/Y
    20.12%
    16.56%
    10.22%
    16.3%
    18.28%
    16.38%
    40.12%
    Tax Rate (%)
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Tax Rate (%)
    • 17.00%
    • 7.00%
    • 15.00%
    • 9.00%
    • 5.00%
    • 13.00%
    • 16.00%
    Y/Y
    50.68%
    55.54%
    106.36%
    28.47%
    49.72%
    20.66%
    24.96%
    Net Income
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Net Income
    • $1.25B
    • $1.24B
    • $1.29B
    • $6.95B
    • $6.00B
    • $7.21B
    • $4.76B
    Y/Y
    3.64%
    1.12%
    3.95%
    10.03%
    13.74%
    12.06%
    33.92%

    Assets & Liabilities | Cash Flow

    Total Assets
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Total Assets
    • $10.53B
    • $10.76B
    • $11.85B
    • $97.15B
    • $98.73B
    • $84.35B
    • $84.49B
    Y/Y
    1.62%
    2.19%
    10.06%
    2.14%
    1.62%
    1.4%
    0.16%
    Total Liabilities
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Total Liabilities
    • $5.23B
    • $4.92B
    • $5.95B
    • $53.01B
    • $51.88B
    • $34.26B
    • $31.00B
    Y/Y
    1.67%
    5.91%
    20.94%
    2.11%
    2.12%
    9.86%
    9.52%
    Capital Expenditures (Capex)
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Capital Expenditures (Capex)
    • -$291.00M
    • -$298.00M
    • -$378.00M
    • -$2.24B
    • -$1.48B
    • -$1.15B
    • -$1.38B
    Y/Y
    53.97%
    2.41%
    26.85%
    11.1%
    34.06%
    10.97%
    20.05%

    Profitability

    Operating Income Margin (%)
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Operating Income Margin (%)
    • 23.63%
    • 19.76%
    • 22.86%
    • 18.69%
    • 16.00%
    • 27.61%
    • 21.77%
    Y/Y
    10.83%
    16.38%
    15.69%
    26.91%
    14.39%
    8.92%
    21.15%
    Net Income Margin (%)
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Net Income Margin (%)
    • 18.31%
    • 18.15%
    • 19.80%
    • 15.47%
    • 13.99%
    • 22.91%
    • 19.94%
    Y/Y
    4.39%
    0.87%
    9.09%
    21.47%
    9.57%
    4.9%
    12.96%
    EBITDA
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    EBITDA
    • $1.99B
    • $1.70B
    • $1.49B
    • $11.94B
    • $11.08B
    • $9.71B
    • $7.50B
    Y/Y
    15.59%
    14.59%
    12.62%
    7.89%
    7.22%
    2.95%
    22.79%
    Free Cash Flow (FCF)
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Free Cash Flow (FCF)
    • $1.02B
    • $1.47B
    • $1.37B
    • $6.91B
    • $6.93B
    • $7.37B
    • $5.78B
    Y/Y
    21.22%
    44.37%
    6.85%
    1.55%
    0.23%
    4.29%
    21.53%

    Ratios

    Return on Equity (ROE)
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Return on Equity (ROE)
    • 23.64%
    • 21.21%
    • 21.85%
    • 15.80%
    • 12.83%
    • 14.39%
    • 8.91%
    Y/Y
    5.3%
    10.28%
    3.02%
    16.58%
    18.8%
    1.05%
    38.08%
    Return on Assets (ROA)
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Return on Assets (ROA)
    • 11.91%
    • 11.52%
    • 10.88%
    • 7.15%
    • 6.07%
    • 8.55%
    • 5.64%
    Y/Y
    5.4%
    3.27%
    5.56%
    11.95%
    15.1%
    10.61%
    34.04%
    Debt to Equity
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Debt to Equity
    • 52.20%
    • 46.79%
    • 57.48%
    • 78.42%
    • 74.70%
    • 39.29%
    • 34.41%
    Y/Y
    3.08%
    10.36%
    22.85%
    7.77%
    4.74%
    19.98%
    12.42%

    Valuation

    Enterprise Value
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Enterprise value
    • $43.08B
    • $31.54B
    • $39.98B
    • $241.83B
    • $231.72B
    • $184.28B
    • $184.05B
    Y/Y
    12.06%
    26.8%
    26.77%
    17.54%
    4.18%
    19.17%
    0.12%
    Enterprise value to Revenue
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Enterprise value to Revenue
    • 6.29
    • 4.62
    • 6.14
    • 5.38
    • 5.41
    • 5.86
    • 7.70
    Y/Y
    18.85%
    26.64%
    33.06%
    28.01%
    0.42%
    24.36%
    31.57%
    Enterprise value to EBITDA
    Years
    • 2022
    • 2023
    • 2024
    • 2022
    • 2023
    • 2022
    • 2023
    Enterprise value to EBITDA
    • 21.61
    • 18.52
    • 26.87
    • 20.25
    • 20.92
    • 18.97
    • 24.54
    Y/Y
    23.92%
    14.29%
    45.08%
    10.48%
    3.28%
    16.72%
    29.35%

    Related company

    Submit feedback to Bullfincher